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Case report
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SummAry
The case is presented of a 73-year-old male with a history of right-sided nasal obstruction, hyponasal speech and three episodes of recur-
rent epistaxis. on examination, there was a tumour in the right nasal cavity. Computed tomography showed a mass in the right nasal cavity 
extending to the right maxillary sinus, ethmoidal cells and right sphenoid sinus. The patient underwent a functional endoscopic removal 
of the tumour. Biopsy revealed a small cell neuroendocrine carcinoma. This is an extremely rare tumour of the nasal cavity and sinuses. 
Because of the aggressive behaviour of this tumour, he was also treated with combined chemotherapy and radiation. Ten months later, he 
remains free of disease.
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riASSunTo
Viene presentato il caso di un uomo di 73 anni con una storia di ostruzione nasale destra persistente, rinolalia chiusa, e tre episodi di 
epistassi ricorrente. All’esame obiettivo, era presente una neoformazione della fossa nasale destra. La tomografia computerizzata ha 
evidenziato la presenza di una massa della cavità nasale destra estesa al seno mascellare, alle cellule etmoidali e al seno sferoidale omola-
terali. Il paziente è stato sottoposto a rimozione della massa nasale per via endoscopica. L’esame istologico ha evidenziato un carcinoma 
neuroendocrino a piccole cellule, che rappresenta un tumore estremamente raro delle fosse nasali. A causa del comportamento aggressivo 
di tale tumore, è stato necessario eseguire un trattamento combinato radio-chemioterapico. Il paziente è libero da malattia a dieci mesi 
dall’esordio.
PArole ChiAve: Fosse nasali • Seni paranasali • Tumori maligni • Carcinoma neuroendocrino a piccole cellule
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Introduction
Primary small cell neuroendocrine carcinoma (SneC) of 
the nasal cavity and sinuses is an extremely rare tumour and 
difficult to diagnose by conventional methods of histologi-
cal examination. not many cases are reported in the litera-
ture and thus analysis of the cases is not an easy procedure. 
ray Chowdhuri first described SneC as a differentiated 
histological entity in the paranasal sinuses in 1965 1.
By 2000, 154 incident cases of primary SneC (interna-
tional Statistical Classification of diseases and related 
health Problems) with histological confirmation had been 
identified. A crude incidence rate of 0.73 SneC cases per 
100,000 inhabitants was estimated using the 2001 Census 
data for the denominator (1.19 per 100,000 among men 
and 0.30 per 100,000 among women).
Although these tumours exhibit morphological features 
similar to those of anaplastic small cell carcinomas of the 
lung and, at first, were thought to arise from the lung, they 
are now considered to be completely different entities due 
to their behavioural differences in relation to metastasis 
and local spread. Also SneC shows similar clinical and 
morphological features to olfactory neuroblastoma (onB) 
and must also be distinguished from this tumour.
The diagnosis of SneC of the head and neck region is 
based on the recognition of the typical neuroendocrine ar-
chitecture and morphology and on the immunohistochem-
ical confirmation of neuroendocrine differentiation.
in the world health organization (who) classification 
of endocrine tumours, SneCs are subdivided into well-
differentiated  tumours,  well-differentiated  carcinomas, 
and poorly differentiated carcinomas depending on their 
histopathological and biological characteristics.
no specific treatment exists, at present, for neuroendo-
crine tumours of the head and neck region, and despite 
the improved histological classification they are mostly 
treated as conventional squamous cell carcinomas or, less 
often, as small cell carcinomas of the lung 2.
in this article, a rare case of SneC, arising from the nasal 
septum, and its management are presented.neuroendocrine carcinoma arising from the septum
51
Fig. 1. Intra-operative endoscopic image of the tumour.
Fig. 2. Positive synaptophysin immunoreactions in neoplastic cells.
Fig. 3. Positive Ki67 immunoreaction in neoplastic cells (90%).
Case report
A 73-year-old man presented at the enT department of 
hippokration general hospital with a long-standing his-
tory of right-sided nasal obstruction, hyponasal speech 
and three episodes of recurrent epistaxis.
Physical examination revealed an exophytic tumour mass of 
the right nasal cavity. Colour of the mucosa over the growth 
varied from white to pink. There were no obvious, palpa-
tive lymph nodes and no distant metastasis was found.
The computed tomography (CT) scan that was carried out 
showed a mass of the right nasal cavity extending to the right 
maxillary sinus, ethmoidal cells and right sphenoid sinus.
general examination revealed that the patient was mod-
erately built and nourished, with normal gait and satisfac-
tory vital signs.
From his past medical history, he had hypertension and 
diabetes mellitus. The patient denied smoking, drinking 
and exposure to radiation or environmental irritants.
Functional endoscopic sinus surgery was used in order to 
remove the mass. upon surgery, a large tumour of the right 
nasal cavity was revealed adjacent to the posterior part of 
the nasal septum and medial wall of the right maxillary si-
nus, invading the middle nasal turbinate. The tumour was 
translucent and polypoid in structure (Fig. 1). during the 
operation, repeated biopsies were taken and were found 
to be positive for malignancy. debulking of the tumour 
carried out in order to define the site of origin, showed 
that the tumour arose from the posterior-superior part of 
the septum. Therefore, complete excision of the mass was 
performed and intra-operative biopsies revealed that the 
margins of the excision were without signs of disease.
The final histological examination showed a small cell 
neuroendocrine carcinoma with poor differentiation. The 
tumour was extremely cellular and composed of sheets or 
nests of small cells. The shape and size of cells were simi-
lar and regular with small amounts of cytoplasm, round 
nuclei, and high mitotic rate. vascular structures and foci 
of necrosis were also present.
immunophenotypic  examination  showed  staining  for 
synaptophysin (Fig. 2), Cd56 and Ki67 (+90%) (Fig. 3), 
while  no  staining  appeared  for  cytokeratin  (CK) Ae1/
Ae3, carcinoembryonic antigen (CeA), CK34be12, leu-
kocyte  (lCA)  or  chromogranin.  immunohistochemical 
reaction for thyroid transcription factor-1 (TTF-1) was 
not necessary because of thorough examination of thyroid 
and lung by CT scan.
The post-operative course was uneventful. due to the ag-
gressive behaviour of this tumour, combined chemothera-
py and radiation were also performed. Close follow-up 10 
months after treatment, through endoscopic examination 
did not reveal any sign of local recurrence.
Discussion
Small cell carcinoma is a very rare and aggressive tumour 
of the sinonasal tract. histologically, it is undistinguishable 
from the anaplastic small cell carcinoma of the lung. They 
both exhibit similar morphological features, as described 
by Koss et al. 3. They are both solid tumours composed of 
sheets, nests and cords of small to intermediate-sized cells e. iacovou et al.
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Fig. 4. Protocol of the French Cervico-facial Carcinological Society.
with high nucleo/cytoplasmic ratio, hyperchromatic nuclei 
with absent or occasional basophilic nucleoli. They also 
have a high mitotic rate with frequent abnormal mitotic 
figures,  necrosis  and  haemorrhage. They  are  both  char-
acterized  by  the  presence  of  electron-dense,  membrane 
bound,  neurosecretory  granules 4.  differential  diagnosis 
must include other malignant tumours such as lymphoma, 
rhabdomyosarcoma, undifferentiated nasopharyngeal car-
cinoma, and undifferentiated sinonasal carcinoma.
of great importance is to distinguish SneC from onB. 
Their relationship remains confusing and controversial. 
hyams et al. 5 proposed a histological grading for onBs 
based on their degree of cellular and architectural dif-
ferentiation. in most cases, SneC should be readily dis-
tinguished from low-grade onB. Sinonasal SneC lacks 
lobular  architecture,  fibrovascular  septa,  neurofibrillary 
stroma, and does not contain neural or olfactory rosettes. 
The anaplastic cells of SneC have neglible cytoplasm, 
high nucleo/cytoplasmic ratio, round or oval dense hy-
perchromatic nuclei, numerous mitotic figures, and apop-
totic cells accompanied by extensive areas of necrosis. 
in contrast, the cells of low-grade onBs show moderate 
amounts of cytoplasm, round nuclei, low nucleo/cytoplas-
mic ratio, and low mitotic activity. necrosis is uncommon 
in low-grade onBs 6. high-grade onBs 5 6 show marked 
nuclear anaplasia and high mitotic activity accompanied 
by prominent necrosis. They also retain the lobular archi-
tecture of well-differentiated tumours, and foci of neuro-
fibrillary stroma with rosette formation are usually identi-
fied 7. These findings are absent in SneC. Furthermore, 
prominent nucleoli are not found in SneC.
immunohistochemistry has not been consistently used to 
distinguish these two entities. SneC lacks the S-100-pos-
itive cells seen at the periphery of the cell nests of onB 
and is negative for nF 6. SneC usually shows staining 
with Ae1:Ae3 or Cam 5.2 antibodies, which is uncom-
mon in onB 6 7.
So far, no study appears to have been presented specifically 
investigating the immunohistochemical features of these 
tumours.  Strong  staining  with  synaptophysin  and  Cd56 
nerve cell adhesion molecule has been reported and weak 
staining with chromogranin A and CAm 5.2/Ae-1 as ap-
pears also in our case 8. Perez-ordonez et al. showed strong 
staining for CAm 5.2 or Ae1:Ae3 in a series of 6 patients. 
expression of neuroendocrine markers, such as nSe, syn-
aptophysin,  and  chromogranin,  although  positive  in  all 
cases, was variable and may be weak with individual mark-
ers, particularly synaptophysin 9. This pattern of staining is 
similar to that found in pulmonary small cell carcinoma.
Clinical manifestations and behaviour of small cell neu-
roendocrine carcinoma do not differ from other tumours of 
the sinonasal tract. it usually presents with epistaxis, nasal 
obstruction, followed by ophthalmic signs (exophthalmos, 
visual acuity trouble and limitation of eye mobility) due 
to orbital involvement. less frequently, other signs sug-
gesting loco-regional invasion have been reported, such 
as local pain and anosmia. Cervical node metastasis has 
also been described 10.
radiographically, the tumour always involves the nasal cav-
ity and multiple paranasal sinuses 11. in our case, the mass 
of the right nasal cavity extended to the right maxillary si-
nus, ethmoidal cells and right sphenoid sinus. CT scan can 
help to diagnose the malignant nature of the tumour, as it 
can reveal the presence of an osteolytic lesion. magnetic 
resonance imaging (mri) with T1, T2 using i.v. gadolinium 
improves differentiation between inflammatory reaction, tu-
mour and liquid retention; mri also identifies the anatomi-
cal relationship between the tumour and the meninges.
little is known about the management of these tumours. 
different  therapeutic  approaches  have  been  used  over 
time. in the 1980s, surgery followed by radiotherapy was 
preferred by the Authors of the largest study 10 and has also 
been recommended more recently 12. in the late 1990s, the 
combination of chemotherapy and radiotherapy, with or 
without surgery was shown to have promising results, for 
neuroblastoma and SneCs of the nasal and paranasal cav-
ities. A retrospective study by e. Babin et al. 13 suggests 
the use of the same protocol that was proposed in the 35th 
Congress of the French Cervico-facial Carginological So-
ciety (november 2003) and is presented in Figure 4.
Although it has no significant effect on tumour growth, bi-
otherapy with somatostatin analogues and/or interferon-α 
is recommended both for well-differentiated and function-
ing tumours. on the other hand, chemotherapy, usually 
with cisplatin and etoposide is effective in the treatment 
of tumours with poor differentiation grade and high pro-
SNEC of nasal and paranasal cavity
Chemotherapy CE = 2 cycles separated by 15-day interval
Cisplatin 33 mg/m2/j for 3 days
Etoposide 100 mg/m2/j for 3 days
 
Evaluation of efficiency by imagery
(Response is the reduction of tumour volume compared with 
pre-treatment volume)
Response > 50%  Response < 50% with tumour  
resection possible  or Response < 50%   
with tumour resection impossible 
 
  Surgery on T and N if N > 0
Radiotherapy 68 Gy  Radiotherapy 68 Gy
Evaluation of efficiency by imagery  Evaluation of efficiency by imagery
Chemotherapy CE  Chemotherapy CEneuroendocrine carcinoma arising from the septum
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liferation rate. Currently, the most used therapeutic op-
tions are: surgery, radiotherapy and chemotherapy as we 
performed in our case, endoscopic removal of the tumour 
with margins free of disease followed by adjuvant radio-
therapy and chemotherapy.
novel  therapies,  new  pharmacological  formulations  and 
more selective somatostatin analogues are now under clinical 
investigation for the treatment of neuroendocrine tumours 14.
extra-pulmonary small cell carcinoma is usually a fatal dis-
ease with a 13% 5-year survival rate 15. in the same retrospec-
tive study of 20 patients 13, recurrences and metastasis have 
been reported to occur after three years in 70% of the patients 
and 4 out of 5 patients in the combined experience of Koss et 
al. 3 and weiss et al. 16 died of disease after a follow-up rang-
ing from 8 months to 2 years. 80% of patients suffering from 
relapses or metastasis within the first two years. The median 
survival time was between two and three years. Common 
metastatic locations are brain, lungs, bones and skin. Four out 
of 6 patients, in the above-mentioned series of Perez-ordonez 
et al. 9 had recurrent disease or died after a mean follow-up of 
37 months. in a study carried out by the mayo Clinic 15, the 
median overall survival of 14 patients with primary head and 
neck tumours was only 14.5 months. unfavourable prognos-
tic factors, such as invasion of the lamina cribosa, have been 
discussed 10. The ectopic hormone syndrome is a predictor of 
bad prognosis and increased mortality of pulmonary SneC 
patients because of the higher risk of cerebral metastasis. The 
endocrine syndrome also seems to negatively affect the prog-
nosis in cases of head and neck SneC 17. other factors, such 
as size of the tumour and number of mitoses, show no cor-
relation with recurrence, metastasis or survival 10. Because of 
the small number of cases in the literature, no conclusions or 
therapeutic recommendations can be made. however, there 
is the need for a multidisciplinary treatment approach com-
bining surgery, radiotherapy and chemotherapy.
in conclusion, sinonasal small cell neuroendocrine carci-
noma is a very rare neoplasm with an aggressive clinical 
behaviour and poor prognosis. it exhibits similar mor-
phological and immunohistochemical features to those of 
anaplastic small cell carcinoma of the lung. it must be 
distinguished from olfactory neuroblastoma. The use of 
current diagnostic ancillary techniques such as, electron 
microscopy and immunohistochemistry can be helpful in 
studying the morphological and biological characteristics 
of the tumour. There are no treatment protocols. however, 
a combined therapy is advantageous.
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